Annual Total Liabilities
$41.83 M
+$1.27 M+3.13%
31 December 2023
Summary:
Black Diamond Therapeutics annual total liabilities is currently $41.83 million, with the most recent change of +$1.27 million (+3.13%) on 31 December 2023. During the last 3 years, it has risen by +$19.92 million (+90.90%). BDTX annual total liabilities is now -79.64% below its all-time high of $205.45 million, reached on 31 December 2019.BDTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$40.47 M
+$1.50 M+3.86%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly total liabilities is currently $40.47 million, with the most recent change of +$1.50 million (+3.86%) on 30 September 2024. Over the past year, it has increased by +$2.40 million (+6.32%). BDTX quarterly total liabilities is now -80.30% below its all-time high of $205.45 million, reached on 31 December 2019.BDTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.1% | +6.3% |
| 3 y3 years | +90.9% | -26.7% |
| 5 y5 years | -37.9% | +770.9% |
BDTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.2% | +90.9% | -26.7% | +8.2% |
| 5 y | 5 years | -79.6% | +90.9% | -80.3% | +770.9% |
| alltime | all time | -79.6% | +184.6% | -80.3% | +770.9% |
Black Diamond Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.47 M(+3.9%) |
| June 2024 | - | $38.97 M(+2.0%) |
| Mar 2024 | - | $38.22 M(-8.6%) |
| Dec 2023 | $41.83 M(+3.1%) | $41.83 M(+9.9%) |
| Sept 2023 | - | $38.06 M(+1.0%) |
| June 2023 | - | $37.68 M(+0.8%) |
| Mar 2023 | - | $37.39 M(-7.8%) |
| Dec 2022 | $40.56 M(-21.7%) | $40.56 M(-14.0%) |
| Sept 2022 | - | $47.19 M(+1.6%) |
| June 2022 | - | $46.46 M(-1.0%) |
| Mar 2022 | - | $46.92 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $51.78 M(+136.3%) | $51.78 M(-6.2%) |
| Sept 2021 | - | $55.18 M(+49.7%) |
| June 2021 | - | $36.86 M(+13.4%) |
| Mar 2021 | - | $32.51 M(+48.3%) |
| Dec 2020 | $21.91 M(-89.3%) | $21.91 M(+14.8%) |
| Sept 2020 | - | $19.09 M(+201.8%) |
| June 2020 | - | $6.33 M(-16.1%) |
| Mar 2020 | - | $7.54 M(-96.3%) |
| Dec 2019 | $205.45 M(+205.0%) | $205.45 M(+4321.2%) |
| Sept 2019 | - | $4.65 M(-93.1%) |
| Dec 2018 | $67.37 M(+358.4%) | $67.37 M |
| Dec 2017 | $14.70 M | - |
FAQ
- What is Black Diamond Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual total liabilities year-on-year change?
- What is Black Diamond Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly total liabilities year-on-year change?
What is Black Diamond Therapeutics annual total liabilities?
The current annual total liabilities of BDTX is $41.83 M
What is the all time high annual total liabilities for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual total liabilities is $205.45 M
What is Black Diamond Therapeutics annual total liabilities year-on-year change?
Over the past year, BDTX annual total liabilities has changed by +$1.27 M (+3.13%)
What is Black Diamond Therapeutics quarterly total liabilities?
The current quarterly total liabilities of BDTX is $40.47 M
What is the all time high quarterly total liabilities for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly total liabilities is $205.45 M
What is Black Diamond Therapeutics quarterly total liabilities year-on-year change?
Over the past year, BDTX quarterly total liabilities has changed by +$2.40 M (+6.32%)